Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.57 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.55 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.49 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.48 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.48 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2443833 | 0.89 | HPGD (0.59) | TRPA1ALDH1A1TDP1KMT2AHPGD | |
| SCHEMBL25867528 | 0.87 | TRPA1 (0.67) | TRPA1ALDH1A1TRPV1KEAP1TDP1 | |
| SCHEMBL7007779 | 0.86 | MAPT (0.61) | TRPA1ALDH1A1TRPV1KMT2AHPGD | |
| SCHEMBL12767039 | 0.85 | TRPA1 (0.60) | TRPA1ALDH1A1TRPV1KEAP1TDP1 | |
| Hydrochloric Acid SCHEMBL9305231 | 0.84 | TRPA1 (0.58) | TRPA1ALDH1A1TRPV1KEAP1TDP1 | |
| SCHEMBL20038751 | 0.84 | TRPA1 (0.58) | TRPA1ALDH1A1TRPV1KEAP1TDP1 | |
| SCHEMBL12446361 | 0.84 | TRPA1 (0.58) | TRPA1ALDH1A1TRPV1KEAP1TDP1 | |
| SCHEMBL19187731 | 0.84 | TRPA1 (0.58) | TRPA1ALDH1A1TRPV1KEAP1TDP1 | |
| SCHEMBL29249334 | 0.83 | TRPA1 (0.53) | TRPA1TRPV1ALOX5 | |
| SCHEMBL7450667 | 0.83 | ALDH1A1 (0.55) | TRPA1ALDH1A1TRPV1KEAP1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105452429-A | Fragrance-containing capsule and cosmetic in which said capsules are blended | SHISEIDO CO LTD | 2016-03-30 | — | — | CN | claimed |
| EP-2463374-A2 | Isolated alcohol dehydrogenase enzymes and uses thereof | Bio Architecture Lab, Inc. (US) | 2012-06-13 | — | — | EP | claimed |
| EP-2195440-A2 | BIOFUEL PRODUCTION | Bio Architecture Lab, Inc. (US) | 2010-06-16 | — | — | EP | claimed |
| US-20090155873-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-18 | — | — | US | claimed |
| US-20090139134-A1 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-06-04 | — | — | US | claimed |
| WO-2009046375-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| WO-2009046370-A2 | BIOFUEL PRODUCTION | BIO ARCHITECTURE LAB, INC. (US) | 2009-04-09 | — | — | WO | claimed |
| CN-1163217-C | Perfume composition | 国际调研有限公司 | 2004-08-25 | — | — | CN | claimed |
| CN-1275075-A | Perfume composition | QUEST INT (NL) | 2000-11-29 | — | — | CN | claimed |
| EP-3230463-B2 | RAPID PRETREATMENT | APALTA PATENTS OUE (EE) | 2025-07-16 | — | — | EP | disclosed |
| US-20240425893-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2024-12-26 | — | — | US | disclosed |
| US-12054761-B2 | Rapid pretreatment | Apalta Patents OÜ (EE) | 2024-08-06 | — | — | US | disclosed |
| US-11821047-B2 | High pressure zone formation for pretreatment | Apalta Patent OÜ (EE) | 2023-11-21 | — | — | US | disclosed |
| US-20230295678-A1 | RAPID PRETREATMENT | Apalta Patents OÜ (EE) | 2023-09-21 | — | — | US | disclosed |
| US-4861683-A | TERPOLYMER OF VINYL CHLORIDE, VINYL MONOMER CONTAINING HYDROXY GROUPS, AND VINYL MONOMER CONTAINING QUATERNARY AMMONIUM GROUPS | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1989-08-29 | — | — | US | disclosed |
| EP-0283609-A1 | Resin for use in magnetic recording media and method of producing the same | SEKISUI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1988-09-28 | — | — | EP | disclosed |
| EP-0093338-A1 | Method for the preparation of cyanohydrine-carboxylic-acid esters | BAYER AG (DE) | 1983-11-09 | — | — | EP | disclosed |
| US-4177177-A | Polymer emulsification process | LEHIGH UNIVERSITY | 1979-12-04 | — | — | US | disclosed |
| US-4085250-A | ORGANO TITANATE LATENT CATALYST | WESTINGHOUSE ELECTRIC CORPORATION (US) | 1978-04-18 | — | — | US | disclosed |
| US-3998983-A | Resin rich epoxide-mica flexible high voltage insulation | WESTINGHOUSE ELECTRIC CORPORATION (US) | 1976-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090139134-A1 | BIOFUEL PRODUCTION | MGAM, DCXR, MANBA | TRPA1 3765/4885ALDH1A1 753/4885TRPV1 3969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.